Assessment of DNA methylation on MGMT gene in patients with glioma (prospective study)

Assessment of DNA methylation on MGMT gene in patients with glioma (a prospective study) - DNA methylation on MGMT gene in glioma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041815

Enrollment

Registered

2020-12-01

Start date

2020-12-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will undergo surgical tumor removal as well as will receive chemotherapy for glioma

Exclusion criteria

Exclusion criteria: Patients who have double cancers

Design outcomes

Primary

Measure	Time frame
Relationship between MGMT methylation and overall survival period	—

Secondary

Measure	Time frame
Relationship between MGMT methylation and progression-free survival period	—

Countries

Japan

Contacts

Public ContactTakaaki Beppu

Iwate Medical University Neurosurgery

tbeppu@iwate-med.ac.jp019-613-7111

Outcome results